K2M Group Holdings Inc (NASDAQ:KTWO) has been given an average recommendation of “Buy” by the fourteen analysts that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, ten have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $24.80.
A number of equities research analysts have recently weighed in on the company. Cantor Fitzgerald assumed coverage on K2M Group in a research note on Thursday, May 31st. They issued an “overweight” rating and a $28.00 price objective for the company. ValuEngine raised K2M Group from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. Oppenheimer set a $24.00 target price on K2M Group and gave the stock a “buy” rating in a research note on Thursday, March 1st. BidaskClub downgraded K2M Group from a “buy” rating to a “hold” rating in a report on Wednesday, March 28th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $23.00 target price on shares of K2M Group in a report on Wednesday, May 2nd.
A number of large investors have recently bought and sold shares of the stock. Engineers Gate Manager LP bought a new position in K2M Group in the first quarter worth about $190,000. Teacher Retirement System of Texas purchased a new position in K2M Group during the 4th quarter worth approximately $213,000. Natixis Advisors L.P. purchased a new position in K2M Group during the 1st quarter worth approximately $229,000. Oppenheimer Asset Management Inc. boosted its stake in shares of K2M Group by 18.0% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 19,285 shares of the medical device company’s stock valued at $366,000 after buying an additional 2,942 shares during the period. Finally, MetLife Investment Advisors LLC acquired a new stake in shares of K2M Group during the 4th quarter valued at $350,000.
KTWO traded down $0.05 during trading on Friday, hitting $22.74. The company’s stock had a trading volume of 1,143 shares, compared to its average volume of 185,824. The firm has a market cap of $1.02 billion, a P/E ratio of -26.08 and a beta of 1.55. K2M Group has a twelve month low of $16.44 and a twelve month high of $25.99. The company has a current ratio of 2.79, a quick ratio of 1.38 and a debt-to-equity ratio of 0.34.
K2M Group (NASDAQ:KTWO) last announced its quarterly earnings data on Tuesday, May 1st. The medical device company reported ($0.26) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.22) by ($0.04). K2M Group had a negative return on equity of 15.38% and a negative net margin of 14.27%. The company had revenue of $67.90 million for the quarter, compared to analysts’ expectations of $66.02 million. During the same quarter in the previous year, the business posted ($0.26) EPS. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. equities research analysts forecast that K2M Group will post -0.72 EPS for the current year.
About K2M Group
K2M Group Holdings, Inc, a medical device company, provides spine and minimally invasive solutions in the United States and internationally. The company offers implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor.
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.